PDB Short entry for 3LCO HEADER TRANSFERASE 11-JAN-10 3LCO TITLE INHIBITOR BOUND TO A DFG-OUT STRUCTURE OF THE KINASE DOMAIN OF CSF-1R COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: CSF-1-R, PROTO-ONCOGENE C-FMS; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSF-1R, CSF1R, FMS; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS ATP-BINDING, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, KEYWDS 2 KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO- KEYWDS 3 ONCOGENE, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KEYWDS 4 KINASE EXPDTA X-RAY DIFFRACTION AUTHOR S.KAMTEKAR,J.E.DAY,B.A.REITZ,K.J.MATHIS,M.J.MEYERS REVDAT 3 21-FEB-24 3LCO 1 REMARK SEQADV REVDAT 2 16-AUG-17 3LCO 1 SOURCE REMARK REVDAT 1 15-SEP-10 3LCO 0 JRNL AUTH M.J.MEYERS,M.PELC,S.KAMTEKAR,J.DAY,G.I.PODA,M.K.HALL, JRNL AUTH 2 M.L.MICHENER,B.A.REITZ,K.J.MATHIS,B.S.PIERCE,M.D.PARIKH, JRNL AUTH 3 D.A.MISCHKE,S.A.LONG,J.J.PARLOW,D.R.ANDERSON,A.THORARENSEN JRNL TITL STRUCTURE-BASED DRUG DESIGN ENABLES CONVERSION OF A DFG-IN JRNL TITL 2 BINDING CSF-1R KINASE INHIBITOR TO A DFG-OUT BINDING MODE. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 1543 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20137931 JRNL DOI 10.1016/J.BMCL.2010.01.078 REMARK 2 REMARK 2 RESOLUTION. 3.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC RIGID BODY REFINEMENT REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 5035 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.247 REMARK 3 R VALUE (WORKING SET) : 0.245 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 250 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.49 REMARK 3 REFLECTION IN BIN (WORKING SET) : 364 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.48 REMARK 3 BIN R VALUE (WORKING SET) : 0.2990 REMARK 3 BIN FREE R VALUE SET COUNT : 23 REMARK 3 BIN FREE R VALUE : 0.3290 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2252 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 68.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.20000 REMARK 3 B22 (A**2) : 1.20000 REMARK 3 B33 (A**2) : -2.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.683 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.550 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 74.386 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.896 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.831 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2345 ; 0.004 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1528 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3184 ; 0.713 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3729 ; 0.721 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 291 ; 4.163 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 97 ;33.017 ;24.021 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 368 ;12.463 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;15.613 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 351 ; 0.041 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2657 ; 0.002 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 472 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1457 ; 0.038 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 593 ; 0.004 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2322 ; 0.072 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 888 ; 0.072 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 861 ; 0.128 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 550 A 665 REMARK 3 ORIGIN FOR THE GROUP (A): -11.0820 18.6335 -24.2707 REMARK 3 T TENSOR REMARK 3 T11: 0.2469 T22: 0.1689 REMARK 3 T33: 0.1808 T12: 0.0226 REMARK 3 T13: 0.0646 T23: -0.0085 REMARK 3 L TENSOR REMARK 3 L11: 4.2510 L22: 5.2314 REMARK 3 L33: 9.1652 L12: 0.3291 REMARK 3 L13: -1.8851 L23: 2.6552 REMARK 3 S TENSOR REMARK 3 S11: -0.1920 S12: 0.0617 S13: -0.4693 REMARK 3 S21: 0.0983 S22: -0.2229 S23: 0.5405 REMARK 3 S31: 0.5852 S32: -0.7668 S33: 0.4148 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 666 A 930 REMARK 3 ORIGIN FOR THE GROUP (A): -2.9947 19.0589 -0.7959 REMARK 3 T TENSOR REMARK 3 T11: 0.1361 T22: 0.0283 REMARK 3 T33: 0.0332 T12: -0.0253 REMARK 3 T13: -0.0045 T23: -0.0104 REMARK 3 L TENSOR REMARK 3 L11: 5.5562 L22: 2.5354 REMARK 3 L33: 2.9864 L12: -0.4238 REMARK 3 L13: 0.4412 L23: 0.3367 REMARK 3 S TENSOR REMARK 3 S11: 0.0422 S12: 0.2593 S13: -0.3259 REMARK 3 S21: -0.2828 S22: -0.0905 S23: -0.0775 REMARK 3 S31: 0.1455 S32: -0.1274 S33: 0.0483 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3LCO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JAN-10. REMARK 100 THE DEPOSITION ID IS D_1000057113. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-APR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07816 REMARK 200 MONOCHROMATOR : DIAMOND [111] REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5285 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.15600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.57900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC RIGID BODY REFINEMENT REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 11 MG/ML PROTEIN INCUBATED WITH 4 MM REMARK 280 INHIBITOR AT 4C OVERNIGHT FOLLOWED BY ADDITION OF 1 UG ARG-C REMARK 280 (PER 50 UL SAMPLE) AT 22C FOR 24 HOURS, FOLLOWED BY ADDITION OF REMARK 280 0.5 UL OF 5 MG/ML LEUPEPTIN, FOLLOWED BY MIXING WITH EQUAL REMARK 280 VOLUMES OF WELL SOLUTION:22.5-35% PEG 4000, 0.1M TRIS-HCL PH 8.5, REMARK 280 0.2M MGCL2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 91.97150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 31.45800 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 31.45800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 137.95725 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 31.45800 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 31.45800 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 45.98575 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 31.45800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 31.45800 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 137.95725 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 31.45800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 31.45800 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.98575 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 91.97150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TRP A 550 REMARK 465 SER A 555 REMARK 465 TYR A 556 REMARK 465 GLU A 557 REMARK 465 GLY A 558 REMARK 465 ASN A 559 REMARK 465 SER A 560 REMARK 465 TYR A 561 REMARK 465 THR A 562 REMARK 465 LEU A 733 REMARK 465 ALA A 734 REMARK 465 PRO A 735 REMARK 465 GLY A 736 REMARK 465 GLN A 737 REMARK 465 ASP A 738 REMARK 465 PRO A 739 REMARK 465 GLU A 740 REMARK 465 GLY A 741 REMARK 465 LEU A 742 REMARK 465 ASP A 743 REMARK 465 LYS A 744 REMARK 465 GLU A 745 REMARK 465 ASP A 746 REMARK 465 LYS A 812 REMARK 465 GLY A 813 REMARK 465 ASN A 814 REMARK 465 ALA A 815 REMARK 465 GLU A 916 REMARK 465 ASP A 917 REMARK 465 ARG A 918 REMARK 465 ARG A 919 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 554 CG CD OE1 OE2 REMARK 470 GLN A 568 CG CD OE1 NE2 REMARK 470 LYS A 574 CG CD CE NZ REMARK 470 LYS A 586 CG CD CE NZ REMARK 470 LYS A 606 CG CD CE NZ REMARK 470 ASP A 625 CG OD1 OD2 REMARK 470 LYS A 627 CG CD CE NZ REMARK 470 GLU A 644 CG CD OE1 OE2 REMARK 470 ASN A 673 CG OD1 ND2 REMARK 470 ASP A 802 CG OD1 OD2 REMARK 470 ILE A 803 CG1 CG2 CD1 REMARK 470 LYS A 864 CG CD CE NZ REMARK 470 LYS A 883 CG CD CE NZ REMARK 470 GLN A 915 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 623 -150.54 -122.28 REMARK 500 ASP A 778 65.78 -164.89 REMARK 500 THR A 787 -167.74 -109.76 REMARK 500 TRP A 893 33.40 -92.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LC0 A 999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3LCD RELATED DB: PDB REMARK 900 A DIFFERENT INHIBITOR COMPLEX DBREF 3LCO A 550 741 UNP P07333 CSF1R_HUMAN 550 695 DBREF 3LCO A 742 919 UNP P07333 CSF1R_HUMAN 742 919 SEQADV 3LCO ALA A 734 UNP P07333 SER 688 CONFLICT SEQRES 1 A 324 TRP LYS ILE ILE GLU SER TYR GLU GLY ASN SER TYR THR SEQRES 2 A 324 PHE ILE ASP PRO THR GLN LEU PRO TYR ASN GLU LYS TRP SEQRES 3 A 324 GLU PHE PRO ARG ASN ASN LEU GLN PHE GLY LYS THR LEU SEQRES 4 A 324 GLY ALA GLY ALA PHE GLY LYS VAL VAL GLU ALA THR ALA SEQRES 5 A 324 PHE GLY LEU GLY LYS GLU ASP ALA VAL LEU LYS VAL ALA SEQRES 6 A 324 VAL LYS MET LEU LYS SER THR ALA HIS ALA ASP GLU LYS SEQRES 7 A 324 GLU ALA LEU MET SER GLU LEU LYS ILE MET SER HIS LEU SEQRES 8 A 324 GLY GLN HIS GLU ASN ILE VAL ASN LEU LEU GLY ALA CYS SEQRES 9 A 324 THR HIS GLY GLY PRO VAL LEU VAL ILE THR GLU TYR CYS SEQRES 10 A 324 CYS TYR GLY ASP LEU LEU ASN PHE LEU ARG ARG LYS ALA SEQRES 11 A 324 GLU ALA MET LEU GLY PRO SER LEU ALA PRO GLY GLN ASP SEQRES 12 A 324 PRO GLU GLY LEU ASP LYS GLU ASP GLY ARG PRO LEU GLU SEQRES 13 A 324 LEU ARG ASP LEU LEU HIS PHE SER SER GLN VAL ALA GLN SEQRES 14 A 324 GLY MET ALA PHE LEU ALA SER LYS ASN CYS ILE HIS ARG SEQRES 15 A 324 ASP VAL ALA ALA ARG ASN VAL LEU LEU THR ASN GLY HIS SEQRES 16 A 324 VAL ALA LYS ILE GLY ASP PHE GLY LEU ALA ARG ASP ILE SEQRES 17 A 324 MET ASN ASP SER ASN TYR ILE VAL LYS GLY ASN ALA ARG SEQRES 18 A 324 LEU PRO VAL LYS TRP MET ALA PRO GLU SER ILE PHE ASP SEQRES 19 A 324 CYS VAL TYR THR VAL GLN SER ASP VAL TRP SER TYR GLY SEQRES 20 A 324 ILE LEU LEU TRP GLU ILE PHE SER LEU GLY LEU ASN PRO SEQRES 21 A 324 TYR PRO GLY ILE LEU VAL ASN SER LYS PHE TYR LYS LEU SEQRES 22 A 324 VAL LYS ASP GLY TYR GLN MET ALA GLN PRO ALA PHE ALA SEQRES 23 A 324 PRO LYS ASN ILE TYR SER ILE MET GLN ALA CYS TRP ALA SEQRES 24 A 324 LEU GLU PRO THR HIS ARG PRO THR PHE GLN GLN ILE CYS SEQRES 25 A 324 SER PHE LEU GLN GLU GLN ALA GLN GLU ASP ARG ARG HET LC0 A 999 33 HETNAM LC0 3-({4-METHOXY-5-[(4-METHOXYBENZYL)OXY]PYRIDIN-2- HETNAM 2 LC0 YL}METHOXY)-5-(1-METHYL-1H-PYRAZOL-4-YL)PYRAZIN-2- HETNAM 3 LC0 AMINE FORMUL 2 LC0 C23 H24 N6 O4 HELIX 1 1 ASN A 572 GLU A 576 5 5 HELIX 2 2 PRO A 578 ASN A 580 5 3 HELIX 3 3 HIS A 623 GLY A 641 1 19 HELIX 4 4 LEU A 671 GLY A 684 1 14 HELIX 5 5 GLU A 751 LYS A 772 1 22 HELIX 6 6 ASP A 802 ASP A 806 5 5 HELIX 7 7 LYS A 820 MET A 822 5 3 HELIX 8 8 ALA A 823 PHE A 828 1 6 HELIX 9 9 THR A 833 PHE A 849 1 17 HELIX 10 10 ASN A 862 GLY A 872 1 11 HELIX 11 11 PRO A 882 TRP A 893 1 12 HELIX 12 12 GLU A 896 ARG A 900 5 5 HELIX 13 13 THR A 902 GLN A 915 1 14 SHEET 1 A 5 LEU A 582 ALA A 590 0 SHEET 2 A 5 GLY A 594 LEU A 604 -1 O GLU A 598 N GLY A 585 SHEET 3 A 5 ALA A 609 LEU A 618 -1 O VAL A 613 N ALA A 599 SHEET 4 A 5 LEU A 660 THR A 663 -1 O VAL A 661 N LYS A 616 SHEET 5 A 5 LEU A 649 CYS A 653 -1 N LEU A 650 O ILE A 662 SHEET 1 B 3 GLY A 669 ASP A 670 0 SHEET 2 B 3 VAL A 784 THR A 787 -1 O LEU A 786 N GLY A 669 SHEET 3 B 3 VAL A 791 ILE A 794 -1 O LYS A 793 N LEU A 785 SHEET 1 C 2 TYR A 809 ILE A 810 0 SHEET 2 C 2 LEU A 817 PRO A 818 -1 O LEU A 817 N ILE A 810 SITE 1 AC1 14 LEU A 588 ALA A 614 LYS A 616 GLU A 633 SITE 2 AC1 14 VAL A 647 THR A 663 GLU A 664 CYS A 666 SITE 3 AC1 14 HIS A 776 ASN A 783 LEU A 785 GLY A 795 SITE 4 AC1 14 ASP A 796 PHE A 797 CRYST1 62.916 62.916 183.943 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015894 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015894 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005436 0.00000